MEN1 and acute myeloid leukemia: Multiple trials investigating menin inhibitors to treat AML are recruiting patients, either as monotherapy (NCT04811560) or in combination with other chemotherapy (NCT05326516, NCT06001788, NCT05453903, NCT04988555, NCT05886049, NCT06284486, NCT04752163).